Blood transfusions are crucial in human and veterinary medicine, yet human blood reserves are in constant need of donors, ...

Ten years have elapsed since the government gave its full policy support for the research field of regenerative medicine centered on iPS cells.

Efforts to foster both intrinsic and extrinsic regenerative responses in heart failure have once again brought iPS cell technologies to the forefront, thanks to their flexibility in reconstructing ...

A research team involved in the recently published successful transplantation of allogeneic iPS cell-derived dopaminergic neural progenitors into patients with Parkinson's disease, led by former ...

A collaborative research team led by Dr. Thorsten Schlaeger (Boston Children's Hospital) Emiri Nakamura and Professor Koji Eto (Department of Clinical Application) has identified microtubule (MT) ...

Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.

Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...

A team of researchers has recently developed a nondestructive imaging and machine learning system that accurately predicts the efficiency of stem cell differentiation into muscle stem cells. The team ...

A pharmaceutical startup plans to begin a clinical trial in 2027 on a treatment for spinal cord injuries that uses nerve ...